https://www.pharma-marketing.com/zeiss-rms-appoints-mediaplus-performance-for-global-media-management/Pharma-Marketing.comen2026-06-23T11:55:28+00:00ZEISS RMS appoints Mediaplus Performance for global media management https://www.pharma-marketing.com/de/zeiss-rms-beauftragt-mediaplus-performance-mit-globaler-media-steuerung/Pharma-Marketing.comde2026-06-23T11:55:28+00:00ZEISS RMS beauftragt Mediaplus Performance mit globaler Media-Steuerung https://www.pharma-marketing.com/aurobindo-usa-receives-ftc-clearance-for-lannett-acquisition/Pharma-Marketing.comen2026-06-23T11:41:10+00:00Aurobindo USA receives FTC clearance for Lannett acquisition https://www.pharma-marketing.com/de/aurobindo-usa-erhaelt-ftc-freigabe-fuer-lannett-uebernahme/Pharma-Marketing.comde2026-06-23T11:41:10+00:00Aurobindo USA erhält FTC-Freigabe für Lannett-Übernahme https://www.pharma-marketing.com/wefra-life-appoints-can-yildiz-as-chief-innovation-officer/Pharma-Marketing.comen2026-06-23T10:58:00+00:00WEFRA LIFE appoints Can Yildiz as Chief Innovation Officer https://www.pharma-marketing.com/de/wefra-life-ernennt-can-yildiz-zum-chief-innovation-officer/Pharma-Marketing.comde2026-06-23T10:57:59+00:00WEFRA LIFE ernennt Can Yildiz zum Chief Innovation Officer https://www.pharma-marketing.com/abbvie-to-acquire-apogee-and-expand-immunology-pipeline/Pharma-Marketing.comen2026-06-23T10:14:10+00:00AbbVie to acquire Apogee and expand immunology pipeline https://www.pharma-marketing.com/de/abbvie-will-apogee-uebernehmen-und-immunologie-pipeline-ausbauen/Pharma-Marketing.comde2026-06-23T10:14:09+00:00AbbVie will Apogee übernehmen und Immunologie-Pipeline ausbauen